[Efficacy of Recombinant Thrombomodulin for Sepsis-Associated Disseminated Intravascular Coagulation Caused by Urinary Tract Infections].
Hinyokika Kiyo
; 69(11): 309-314, 2023 Nov.
Article
em Ja
| MEDLINE
| ID: mdl-38031329
ABSTRACT
Severe urinary tract infections occasionally cause sepsis and disseminated intravascular coagulation (DIC). We examined the efficacy of recombinant thrombomodulin (rTM) for treating DIC caused by urosepsis. We enrolled 40 patients who were diagnosed with DIC caused by urosepsis at our hospital between April 2018 and May 2022. Twenty-six patients were treated with rTM (rTM group), while 14 patients did not receive rTM (non-rTM group). The DIC score before treatment in the rTM group was significantly higher than that in the non-rTM group (Pï¼0.01). There was no significant difference in disease-specific survival between the two groups. There was a significant improvement in DIC scores on days 1-3 after administering rTM. However, the duration of DIC in the rTM group was significantly longer than that in the non-rTM group (Pï¼0.038). The administration of rTM may have benefits in patients with DIC caused by urosepsis.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Infecções Urinárias
/
Trombomodulina
/
Sepse
/
Coagulação Intravascular Disseminada
Limite:
Humans
Idioma:
Ja
Revista:
Hinyokika Kiyo
Ano de publicação:
2023
Tipo de documento:
Article